| answer text |
<p>Through a joint rolling research call for COVID-19 research between the National
Institute for Health Research and UK Research and Innovation, funding of over £500,000
has been committed to a study looking at the safety and immunogenicity of two candidate
COVID-19 vaccines administered to the respiratory tract in aerosol form, with an expected
end date in August 2021.</p><p>In addition, Innovate UK, have been managing the delivery
of £75 million of the £110 million Department-funded UK Vaccine Network programme.
Nine Departmental projects within this portfolio were repurposed to identify other
COVID-19 vaccines solutions. Also, two Innovate UK grants worth over £2.2 million
in total, were awarded to Stabilitech, now known as IosBio, to assess its COVD-19
vaccine candidate that has an oral capsule delivery system in animal efficacy studies.
This technology is now being tested in participants in clinical trials in South Africa
and the United States.</p>
|
 |
